General Information of Drug (ID: DM186ZV)

Drug Name
PAZELLIPTINE TRIHYDROCHLORIDE
Synonyms SR-95225B; BD-40 (free base); Pazelliptine trihydrochloride; 10-[3-(Diethylamino)propylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinoline trihydrochloride
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H27N5
Canonical SMILES
CCN(CC)CCCNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CN=C4)C
InChI
1S/C22H27N5/c1-4-27(5-2)12-6-9-24-22-18-13-17-19-14-23-10-8-20(19)26-21(17)15(3)16(18)7-11-25-22/h7-8,10-11,13-14,26H,4-6,9,12H2,1-3H3,(H,24,25)
InChIKey
LPHSYQSMAGVYNT-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
68853
CAS Number
65222-35-7
TTD ID
D0C9EE

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004215)